Investors of Perrigo Company Urged to Join Class Action Lawsuit Before Deadline

In recent news, Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors in Perrigo Company plc (NYSE: PRGO) who have sustained noteworthy losses. Those who purchased or acquired PRGO securities between February 27, 2023, and November 4, 2025, now have the chance to lead a class action lawsuit against the company. This urgent announcement comes with a deadline set for January 16, 2026, prompting affected investors to take swift action.

Background on the Lawsuit

The class action lawsuit, titled French v. Perrigo Company plc, has been filed in the Southern District of New York and accuses Perrigo, along with its top executives, of violating the Securities Exchange Act of 1934. The primary allegations concern actions taken during and after Perrigo's acquisition of Nestlé's infant formula business, which has faced scrutiny over its management and operational practices.

Robbins Geller asserts that this acquisition, completed in November 2022 for $170 million, led to significant complications. The complaint suggests that the new subsidiary was burdened with substantial operational deficiencies, leading to an inflated assessment of Perrigo's overall financial health. Particularly, the lawsuit claims that the management failed to disclose critical issues such as underinvestment in essential maintenance and hidden manufacturing problems that significantly impacted the company's profitability.

Financial Impact and Stock Value Decline

The allegations have had severe repercussions on Perrigo's financial standing. For instance, on February 27, 2024, the company revealed a staggering financial burden due to its newly acquired infant formula business, announcing additional costs of $35 million to $45 million needed for remediation efforts. This news led to an immediate drop in stock price of more than 15%.

Further disclosures throughout 2024 indicated alarming declines in earnings, with net sales falling 34.5% by May 7, 2024, primarily due to disruptions associated with the infant formula plant. The stock price took another hit, plummeting by nearly 10% in response to this news, raising concerns among investors about the company's transparency and ability to recover.

The challenges were compounded on August 6, 2025, when Perrigo reported decreased gross profits and margins, leading to an over 11% stock drop. Most recently, on November 5, 2025, the company announced it was re-evaluating its investment strategy in the infant formula business, further slashing its fiscal growth outlook. Such disclosures have contributed to a dramatic 25% fall in stock price following these revelations.

The Lead Plaintiff Process

Under the Private Securities Litigation Reform Act of 1995, investors who acquired PRGO securities during the class period are encouraged to seek the appointment as lead plaintiff. The lead plaintiff generally represents the interests of all affected class members and has the authority to select a law firm of their choice to handle the litigation process. Importantly, involvement as a lead plaintiff does not restrict other investors' potential recovery from the case.

For those interested, details on how to proceed are outlined on the Robbins Geller website and additional support can be sought through direct contact with their legal team.

About Robbins Geller Rudman & Dowd LLP

Robbins Geller is recognized globally for its expertise in representing investors in cases of securities fraud. The firm has an exceptional record of securing monumental settlements for clients in the realm of shareholder litigation. With a seasoned team of approximately 200 lawyers operating out of ten offices, Robbins Geller has established itself as a leader in the field,
consistently achieving significant recoveries for investors.

Conclusion
Timing is crucial for investors in Perrigo Company who have experienced significant losses. The deadline to join the class action lawsuit is fast approaching, and potential class members are strongly encouraged to assess their situation and consult the legal experts at Robbins Geller to explore their options for recovery. As the case unfolds, it highlights the imperative for transparency and responsibility within corporate practices, ensuring that shareholder interests are duly protected.